Anteo Diagnostics Ltd has released a press release.
AnteoTech Developing Multiplex Test for COVID-19
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- AnteoTech Advances Battery Technology Program
- AnteoTech and Axxin Build Successful Sepsis Multiplex Test
- R & D Refund Received
- Rights Issue Raises $2.15 million
- Heads of Agreement signed with Merck
Later from AnteoTech
- AnteoTech Secures $3.76M Option Underwriting Agreement
- Preliminary Final Report
- AnteoTech COVID-19 Antigen Test Progress Update
- AnteoTech Achieve ISO-13485 Certification
- Study Confirms Targeted Sensitivity of COVID-19 Test
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech